Biolase, Inc. short interest in 2021
In 2021, Biolase, Inc.'s disclosed short interest ran from 5.69% of shares outstanding on 31 Mar 2021 to 4.34% on 31 Dec 2021, a change of -1.35 percentage points. The year's high was 5.69% on 31 Mar 2021 and its low 2.59% on 15 Jul 2021, averaging 3.95% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.33 days on 30 Sep 2021. Full history: Biolase, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2021 in figures
- Start of year
- 5.69% (31 Mar 2021)
- End of year
- 4.34% (31 Dec 2021)
- Change
- -1.35 pp
- High
- 5.69% (31 Mar 2021)
- Low
- 2.59% (15 Jul 2021)
- Average
- 3.95%
- Highest days to cover
- 4.33 (30 Sep 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2021 | 5.69% | 1.61 | results (8-K), 10-K filed |
| 15 Apr 2021 | 5.57% | 1.00 | |
| 30 Apr 2021 | 5.30% | 2.33 | |
| 14 May 2021 | 4.02% | 2.25 | 10-Q filed, results (8-K) |
| 28 May 2021 | 4.16% | 2.31 | |
| 15 Jun 2021 | 3.51% | 1.20 | |
| 30 Jun 2021 | 3.29% | 2.43 | |
| 15 Jul 2021 | 2.59% | 2.55 | |
| 30 Jul 2021 | 2.89% | 3.51 | |
| 13 Aug 2021 | 2.87% | 1.00 | results (8-K), 10-Q filed |
| 31 Aug 2021 | 3.96% | 1.11 | |
| 15 Sep 2021 | 3.84% | 3.19 | |
| 30 Sep 2021 | 3.76% | 4.33 | |
| 15 Oct 2021 | 3.54% | 3.88 | |
| 29 Oct 2021 | 3.48% | 3.47 | |
| 15 Nov 2021 | 3.80% | 2.00 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 4.45% | 1.41 | |
| 15 Dec 2021 | 3.91% | 1.76 | |
| 31 Dec 2021 | 4.34% | 1.23 |
See also: Biolase, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.